Skip to main content

Table 4 Comparison of haematological parameters at different points in the study. Values are expressed as median (range)

From: A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain

 Baselinep*12 monthsp**24 monthsp***30 monthsp****
HCT0.39(0.33–0.47)0.0080.42(0.36–0.47)0.740.42(0.38–0.46)p <  0.0010.41 (0.37–0.46)0.16
RBCs4.48 (3.66–5.13)0.0084.67(3.66–5.13)0.424.77(4.20–5.62)P <  0.0014.6 (4.14–5.23)0.07
Neutrophils4.8 (2.10–9.50)0.0424.1(1.40–6.86)0.163.5(0.31–6.12)p = 0.0074.31(3–6.56)0.18
Monocytes0.54 (0.20–1.10)0.0090.45(0.24–0.70)0.180.46(0.30–0.60)p = 0.340.53 (0.30–0.91)0.13
  1. p* baseline vs 12 months.
  2. p** 12 months vs 24 months.
  3. p*** baseline vs 24 months.
  4. p**** 24 months vs 30 months.